GENE ONLINE|News &
Opinion
Blog

Alnylam Pharmaceuticals
FDA Approves Alnylam’s Rare Disease RNAi Therapeutic
2022-06-15
Alnylam Challenges Moderna and Pfizer with Patent Infringement
2022-03-18
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
Alnylam Aims to Obtain “Top 5 Biotech” Tag By 2025
2021-01-12
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
Intellia Trials CRISPR Drug as Permanent Cure to Fatal Hereditary Disease
2020-10-21
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
JP Morgan Healthcare Conference 2020 Updates
2020-01-16
The 38th Annual J.P. Morgan Healthcare Conference – What to Expect?
2020-01-13
FDA approves second RNAi based drug
2019-11-20
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top